Evidence map›Paper›PMID 38782592›Full record

ArticleAJNR. American journal of neuroradiology2024

Timing of Spot Sign Appearance, Spot Sign Volume, and Leakage Rate among Phases of Multiphase CTA Predict Intracerebral Hemorrhage Growth.

MacKenzie Horn, Ericka Teleg, Koji Tanaka, Abdulaziz Al Sultan, Linda Kasickova, Tomoyuki Ohara, Piyush Ojha, Sanchea Wasyliw, Sina Marzoughi, Ankur Banerjee and 11 more

Abstract read
In one paragraph

Article in AJNR. American journal of neuroradiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

MacKenzie HornFrom the Foothills Medical Centre, Department of Clinical Neurosciences (M.H., E.T., K.T., A.A.S., P.O., K.H., A. Bobyn, A.N., N.S., B.K.M., A.M.D.), University of Calgary, Calgary, Alberta, Canada.ORCID 0000-0002-1472-3977
Ericka TelegFrom the Foothills Medical Centre, Department of Clinical Neurosciences (M.H., E.T., K.T., A.A.S., P.O., K.H., A. Bobyn, A.N., N.S., B.K.M., A.M.D.), University of Calgary, Calgary, Alberta, Canada.
Koji TanakaFrom the Foothills Medical Centre, Department of Clinical Neurosciences (M.H., E.T., K.T., A.A.S., P.O., K.H., A. Bobyn, A.N., N.S., B.K.M., A.M.D.), University of Calgary, Calgary, Alberta, Canada.ORCID 0000-0001-6501-4057
Abdulaziz Al SultanFrom the Foothills Medical Centre, Department of Clinical Neurosciences (M.H., E.T., K.T., A.A.S., P.O., K.H., A. Bobyn, A.N., N.S., B.K.M., A.M.D.), University of Calgary, Calgary, Alberta, Canada.ORCID 0000-0003-2849-5386
Linda KasickovaDepartment of Neurology (L.K.), University Ostrava, Ostrava, Czech Republic.
Tomoyuki OharaDepartment of Neurology (T.O.), Kyoto Prefectural University of Medicine, Kyoto, Japan.
Piyush OjhaFrom the Foothills Medical Centre, Department of Clinical Neurosciences (M.H., E.T., K.T., A.A.S., P.O., K.H., A. Bobyn, A.N., N.S., B.K.M., A.M.D.), University of Calgary, Calgary, Alberta, Canada.ORCID 0000-0001-7659-0383
Sanchea WasyliwDepartment of Medicine (S.W.), Division of Neurology, University of Saskatchewan, Saskatoon, Canada.
Sina MarzoughiDepartment of Medicine (S.M.), Division of Neurology, University of British Columbia, Vancouver, British Columbia, Canada.
Ankur BanerjeeDepartment of Medicine (A. Banerjee), Division of Neurology, University of Alberta, Edmonton, Alberta, Canada.
Girish KulkarniDepartment of Neurology (G.K.), National Institute of Mental Health and Neurosciences, Bengaluru, India.
Kennedy HornFrom the Foothills Medical Centre, Department of Clinical Neurosciences (M.H., E.T., K.T., A.A.S., P.O., K.H., A. Bobyn, A.N., N.S., B.K.M., A.M.D.), University of Calgary, Calgary, Alberta, Canada.
Amy BobynFrom the Foothills Medical Centre, Department of Clinical Neurosciences (M.H., E.T., K.T., A.A.S., P.O., K.H., A. Bobyn, A.N., N.S., B.K.M., A.M.D.), University of Calgary, Calgary, Alberta, Canada.
Anneliese NewedukFrom the Foothills Medical Centre, Department of Clinical Neurosciences (M.H., E.T., K.T., A.A.S., P.O., K.H., A. Bobyn, A.N., N.S., B.K.M., A.M.D.), University of Calgary, Calgary, Alberta, Canada.
Nishita SinghFrom the Foothills Medical Centre, Department of Clinical Neurosciences (M.H., E.T., K.T., A.A.S., P.O., K.H., A. Bobyn, A.N., N.S., B.K.M., A.M.D.), University of Calgary, Calgary, Alberta, Canada.ORCID 0000-0003-3647-0904
Wu QiuDepartment of Biomedical Engineering (W.Q.), Huazhong University of Science and Technology, Wuhan, China.ORCID 0000-0001-7827-8270
David Rodriguez-LunaDepartment of Neurology (D.R.-L.), Vall d'Hebron University Hospital, Barcelona, Spain.ORCID 0000-0001-8053-4536
Dar DowlatshahiDepartment of Medicine (D.D.), Division of Neurology, University of Ottawa, Ottawa, Ontario, Canada.ORCID 0000-0003-1379-3612
Mayank GoyalDepartment of Radiology (M.G., B.K.M., A.M.D.), University of Calgary, Calgary, Alberta, Canada.ORCID 0000-0001-9060-2109
Bijoy K MenonFrom the Foothills Medical Centre, Department of Clinical Neurosciences (M.H., E.T., K.T., A.A.S., P.O., K.H., A. Bobyn, A.N., N.S., B.K.M., A.M.D.), University of Calgary, Calgary, Alberta, Canada.ORCID 0000-0002-3466-496X
Andrew M DemchukFrom the Foothills Medical Centre, Department of Clinical Neurosciences (M.H., E.T., K.T., A.A.S., P.O., K.H., A. Bobyn, A.N., N.S., B.K.M., A.M.D.), University of Calgary, Calgary, Alberta, Canada ademchuk@ucalgary.ca.ORCID 0000-0002-4930-7789

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeThe presence of spot sign is associated with a high risk of hematoma growth. Our aim was to investigate the timing of the appearance, volume, and leakage rate of the spot sign for predicting hematoma growth in acute intracerebral hemorrhage using multiphase CTA. MATERIALS AND

methodsIn this single-center retrospective study, multiphase CTA in 3 phases was performed in acute intracerebral hemorrhage (defined as intraparenchymal ± intraventricular hemorrhages). Phases of the spot sign first appearance, spot sign volumes (microliter), and leakage rates among phases (microliter/second) were measured. Associations between baseline clinical and imaging variables including spot sign volume parameters (volume and leakage rate divided by median) and hematoma growth (>6 mL) were investigated using regression models. Receiver operating characteristic analysis was used as appropriate.

resultsTwo hundred seventeen patients (131 men; median age, 70 years) were included. The spot sign was detected in 21.7%, 30.0%, and 29.0% in the first, second, and third phases, respectively, with median volumes of 19.7, 31.4, and 34.8 μl in these phases. Hematoma growth was seen in 44 patients (20.3%). By means of modeling, the following variables, namely the spot sign appearing in the first phase, first phase spot sign volume, spot sign appearing in the second or third phase, and spot sign positive and negative leakage rates, were associated with hematoma growth. Among patients with a spot sign, the absolute leakage rate accounting for both positive and negative leakage rates was also associated with hematoma growth (per 1-μl/s increase; OR, 1.26; 95% CI, 1.04-1.52). Other hematoma growth predictors were stroke history, baseline NIHSS score, onset-to-imaging time, and baseline hematoma volume (all

conclusionsThe timing of the appearance of the spot sign, volume, and leakage rate were all associated with hematoma growth. Development of automated software to generate these spot sign volumetric parameters would be an important next step to maximize the potential of temporal intracerebral hemorrhage imaging such as multiphase CTA for identifying those most at risk of hematoma growth.

Indexed as

Cerebral HemorrhageAgedAged, 80 and overCerebral AngiographyComputed Tomography AngiographyDisease ProgressionFemaleHematomaHumansMaleMiddle AgedPredictive Value of TestsRetrospective Studies

Identifiers

PMID38782592
PMCPMC11288591

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.